1. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev. 2002; 23:120–40.
Article
2. Sybert VP, Mccauley E. Turner's syndrome. N Engl J med. 2004; 351:1227–38.
Article
3. Jang GC, Shin HJ, Kim DH. Clinical manifestations according to karyotype in Turner syndrome. J Korean Soc Pediatr Endocrinol. 2000; 5:163–70.
4. Goodyer PR, Fong JS, Kaplan BS, Milner LS, Lotan D, Mills M. Turner's syndrome, 46X, delX(P11), Persistent complement activation and membranopro-liferative glomerulonephritis. Am J Nephrol. 1982; 2:272–5.
5. Chan PC, Cheng IK, Chan MK. FSGS and mosaic Turner's syndrome. Clin Nephrol. 1989; 32:149–50.
6. Wattad A, Jain J, Kerrigan J, Youngberg G. FSGS and Turner's syndrome. Nephron. 1998; 80:106.
7. Suzuki K, Tanaka H, Ito E, Waga S. Therapy-related membranous nephropathy in juvenile idiopathic arthritis with Turner syndrome. Pediatr Int. 2004; 46:377–9.
Article
8. Nakamura S, Koshino H, Kon S, Soeda Y, Iwanami N, Ohtsu S, et al. Membranous nephropathy occurred in a patient with Turner's syndrome during rhGH treatment. Kitasato Med J. 2013; 43:79–81.
9. Deegens JK, Dijkman HB, Borm GF, Steenbergen EJ, van den Berg JG, Weening JJ, et al. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int. 2008; 74:1568–76.
Article
10. McKusick VA. The anatomy of the human genome. Hosp Pract(Hosp Ed). 1981; 16:82–100.
Article
11. Praga M, Morales E, Herrero JC, Perez CA, Dominguez GB, Alegre R, et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyper-filtration. Am J Kidney Dis. 1999; 33:52–8.
Article